News20/10/2026
OpenAI acquires a16z portfolio issuer Orchestra Bio
Andreessen Horowitz →OpenAI announced that it had acquired Orchestra Bio, a drug-development coordination platform listed in a16z's historical portfolio. The page URL retains to-acquire wording, but the opened body expressly confirms acquisition. No investor-specific realization or proceeds are reported.